These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34046513)

  • 1. Emergence of Human Immunodeficiency Virus-1 Drug Resistance During the 3-Month World Health Organization-Recommended Enhanced Adherence Counseling Period in the CART-1 Cohort Study.
    Brown JA; Mbunkah HA; Lejone TI; Ringera I; Cheleboi M; Klimkait T; Metzner KJ; Günthard HF; Labhardt ND; Kouyos RD; Tschumi N
    Open Forum Infect Dis; 2021 May; 8(5):ofab046. PubMed ID: 34046513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When patients fail UNAIDS' last 90 - the "failure cascade" beyond 90-90-90 in rural Lesotho, Southern Africa: a
    Labhardt ND; Ringera I; Lejone TI; Cheleboi M; Wagner S; Muhairwe J; Klimkait T
    J Int AIDS Soc; 2017 Jul; 20(1):21803. PubMed ID: 28777506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Treatment Cascade in Children With Unsuppressed Viral Load-A Reality Check in Rural Lesotho, Southern Africa.
    Lejone TI; Ringera I; Cheleboi M; Wagner S; Muhairwe J; Klimkait T; Labhardt ND
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):250-256. PubMed ID: 29189416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings.
    Labhardt ND; Bader J; Lejone TI; Ringera I; Hobbins MA; Fritz C; Ehmer J; Cerutti B; Puga D; Klimkait T
    Medicine (Baltimore); 2016 Jul; 95(28):e3985. PubMed ID: 27428189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
    BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaching Viral Suppression Among People With HIV With Suspected Treatment Failure who Received Enhanced Adherence Counseling in Southern Nigeria: A Retrospective Analysis.
    Akpan U; Nwanja E; Ukpong KA; Toyo O; Nwaokoro P; Sanwo O; Gana B; Badru T; Idemudia A; Pandey SR; Khamofu H; Bateganya M
    Open Forum Infect Dis; 2022 Dec; 9(12):ofac651. PubMed ID: 36589481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Phone-Based Enhanced Adherence Counseling (EAC) Among Virally Unsuppressed Key Population (KP).
    Ekejiuba C; Timbri T; Chizoba AF; Dalley O; Gurjar U; Ekejiuba GT; Enejoh V; Olayiwola O; Oko JO; Effiong A; Ikechukwu U; Udegbunam C; Oji L; Okobi OE
    Cureus; 2023 Apr; 15(4):e38005. PubMed ID: 37223168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India.
    Laxmeshwar C; Acharya S; Das M; Keskar P; Pazare A; Ingole N; Mehta P; Gori P; Mansoor H; Kalon S; Singh P; Mathur T; Ferlazzo G; Isaakidis P
    PLoS One; 2020; 15(5):e0232576. PubMed ID: 32369504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized enhanced adherence counseling for improved HIV viral suppression among children and adolescents in Homa Bay and Turkana Counties, Kenya.
    Masaba RO; Woelk G; Herrera N; Siamba S; Simiyu R; Ochanda B; Okomo G; Odionyi J; Audo M; Mwangi E
    Medicine (Baltimore); 2022 Oct; 101(40):e30624. PubMed ID: 36221325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Namane T; Mpholo T; Battegay M; Klimkait T; Labhardt ND
    PLoS Med; 2020 Sep; 17(9):e1003325. PubMed ID: 32936795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
    Bvochora T; Satyanarayana S; Takarinda KC; Bara H; Chonzi P; Komtenza B; Duri C; Apollo T
    PLoS One; 2019; 14(2):e0211326. PubMed ID: 30721229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa.
    Sigaloff KC; Hamers RL; Wallis CL; Kityo C; Siwale M; Ive P; Botes ME; Mandaliya K; Wellington M; Osibogun A; Stevens WS; van Vugt M; de Wit TF;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):23-31. PubMed ID: 21694603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.
    McCluskey SM; Boum Y; Musinguzi N; Haberer JE; Martin JN; Hunt PW; Marconi VC; Bangsberg DR; Siedner MJ
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):183-187. PubMed ID: 28628529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral Adherence, Elevated Viral Load, and Drug Resistance Mutations in Human Immunodeficiency Virus-infected Women Initiating Treatment in Pregnancy: A Nested Case-control Study.
    Myer L; Redd AD; Mukonda E; Lynch BA; Phillips TK; Eisenberg A; Hsiao NY; Capoferri A; Zerbe A; Clarke W; Lesosky M; Breaud A; McIntyre J; Bruno D; Martens C; Abrams EJ; Reynolds SJ
    Clin Infect Dis; 2020 Jan; 70(3):501-508. PubMed ID: 30877752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
    Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
    HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
    Eholie SP; Moh R; Benalycherif A; Gabillard D; Ello F; Messou E; Zoungrana J; Diallo I; Diallo M; Bado G; Cisse M; Maiga AI; Anzian A; Toni TD; Congo-Ouedraogo M; Toure-Kane C; Seydi M; Minta DK; Sawadogo A; Sangaré L; Drabo J; Karcher S; Le Carrou J; de Monteynard LA; Peytavin G; Gabassi A; Girard PM; Chaix ML; Anglaret X; Landman R;
    Lancet HIV; 2019 Nov; 6(11):e750-e759. PubMed ID: 31601544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.
    Boender TS; Hamers RL; Ondoa P; Wellington M; Chimbetete C; Siwale M; Labib Maksimos EE; Balinda SN; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Stevens W; Rinke de Wit TF; Sigaloff KC
    J Infect Dis; 2016 Sep; 214(6):873-83. PubMed ID: 27402780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.
    Germanaud D; Derache A; Traore M; Madec Y; Toure S; Dicko F; Coulibaly H; Traore M; Sylla M; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Jan; 65(1):118-24. PubMed ID: 19933171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Viral Load Count and Its Predictors Among Unsuppressed Viral Load Patients Receiving an Enhanced Adherence Counseling Intervention at Three Hospitals in Northern Ethiopia: An Exploratory Retrospective Follow-Up Study.
    Diress G; Linger M
    HIV AIDS (Auckl); 2020; 12():869-877. PubMed ID: 33324112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.